AdvanCell is a vertically integrated radiopharmaceutical company developing a revolutionary cancer treatment called Targeted Alpha Therapy, providing new hope for patients with untreatable cancers.
AdvanCell’s pipeline is powered by innovative technology and a novel approach that ensures a reliable and scalable supply of alpha therapies to drive clinical development and guarantee commercial-scale supply.